Alice Indini

27PUBLICATIONS
73CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsChemotherapyCancer cell biologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (27)

|May 04, 2026
Discontinuation of combo immunotherapy and outcome of patients with melanoma brain metastases.

|May 04, 2026
CAR-engineering of innate and innate-like immune cells: a new horizon in adoptive cell therapy for solid tumors.

|Mar 05, 2025
Dabrafenib and Trametinib for the Treatment of Pediatric and Adolescent Melanoma: Single Center Experience Data From Italian Compassionate Use.

Stefano Chiaravalli, Alice Indini, Michele Del Vecchio

|Apr 12, 2023
Safety of extended interval dosing immune checkpoint inhibitors: a multicenter cohort study.

Luca Cantini, Francesco Paoloni, Federica Pecci

|Sep 09, 2022
NAD/NAMPT and mTOR Pathways in Melanoma: Drivers of Drug Resistance and Prospective Therapeutic Targets.

Alice Indini, Irene Fiorilla, Luca Ponzone

|Mar 21, 2022
BYL719 (alpelisib) for the treatment of PIK3CA-mutated, recurrent/advanced cervical cancer.

Giorgio Bogani, Valentina Chiappa, Marta Bini

Pageof 5

Frequent Collaborators

6 joint publications

Francesco Grossi

6 joint publications

Michele Ghidini

4 joint publications

Andrea Ferrari

3 joint publications

Donatella Gambini